Heron Therapeutics, Inc. (HRTX) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Heron Therapeutics, Inc. (HRTX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $144.4M, listed on NASDAQ, employing roughly 122 people, carrying a beta of 1.71 to the broader market. Heron Therapeutics, Inc. Led by Craig Alexander Collard, public since 1987-08-26.
Snapshot as of May 15, 2026.
- Spot Price
- $0.85
- Total OI
- 42.8K